vTv Therapeutics VTVT
NASDAQ VTVT
$33.35 -0.12 (-0.36%)
At close: Sep 4, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Cash from Investing Activities (2014 - 2023)

vTv Therapeutics' (VTVT) quarterly Cash from Investing Activities came in at $4.4 million in Q4 2023, up 6576.47% quarter-over-quarter from -$68000.0 in Q4 2019.

Analysis

vTv Therapeutics (VTVT) Cash from Investing Activities (2014 - 2023) Analysis & Trends

vTv Therapeutics has disclosed Cash from Investing Activities across 6 years of filings, most recently posting $4.4 million for Q4 2023.

  • In Q4 2023, Cash from Investing Activities changed N/A year-over-year to $4.4 million; the TTM figure through Dec 2023 stood at $4.4 million (changed N/A YoY), while the FY2023 annual figure was $4.4 million, up 21071.43% from the prior year.
  • Cash from Investing Activities came in at $4.4 million for Q4 2023 at vTv Therapeutics, up from -$68000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $4.4 million in Q4 2023 to a low of -$68000.0 in Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -1.11 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -1.20 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -5.60 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -3.11 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 2.11 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -424.26 Mn
7 Revolution Medicines 45.00 Bn 45.00 Bn - -1.66 Bn
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn -49.35 Mn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -51.79 Mn
10 vTv Therapeutics 413.85 Mn 413.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 4.40 Mn
Dec 31, 2019 -68,000.00
Sep 30, 2018 -5,000.00
Mar 31, 2018 12,000.00
Dec 31, 2017 -18,000.00
Sep 30, 2017 32,000.00
Mar 31, 2017 -39,000.00
Dec 31, 2015 -37,000.00
Sep 30, 2015 -9,000.00
Jun 30, 2015 -29,000.00
Mar 31, 2015 -4,000.00
Dec 31, 2014 196,000.00
Sep 30, 2014 -9,000.00